U.S. Physical Therapy (NYSE:USPH) Earns "Outperform" Rating from Barrington Research
Barrington Research has reiterated its "outperform" rating for U.S. Physical Therapy (NYSE:USPH), setting a price objective of $103.00, suggesting a potential 19.41% upside. Other analysts also hold positive views, contributing to a "Moderate Buy" consensus rating and a target price of $105.33. The article details recent stock performance, institutional trading activity, and provides an overview of U.S. Physical Therapy.
U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended December 31, 2025 Earnings Release and Conference Call Dates
U.S. Physical Therapy, Inc. (USPH) announced it will release its financial results for the fourth quarter and year ended December 31, 2025, on Wednesday, February 25, 2026, after the market closes. A conference call to discuss these results will follow on Thursday, February 26, 2026, at 10:30 am Eastern. The company, founded in 1990, operates and/or manages 780 outpatient physical therapy clinics and provides industrial injury prevention services across 44 states.
U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended December 31, 2025 Earnings Release and Conference Call Dates
U.S. Physical Therapy, Inc. (USPH) announced it will release its financial results for the fourth quarter and year ended December 31, 2025, on February 25, 2026. A conference call to discuss these results will follow on February 26, 2026, at 10:30 am Eastern time. Investors can access the live call via dial-in or through the company's website under the Investor Relations section.
U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Evaluating a 24.68% Potential Upside for Investors
U.S. Physical Therapy, Inc. (USPH) presents a compelling investment opportunity with a potential upside of 24.68%, according to analyst ratings. The company, with a market cap of $1.28 billion, shows strong financial health with 17.30% revenue growth, a 2.13% dividend yield, and solid free cash flow. Technical indicators suggest an upward trend, making USPH an attractive option in the healthcare sector for investors seeking long-term appreciation.
The Bull Case For U.S. Physical Therapy (USPH) Could Change Following NYU Langone Alliance - Learn Why
U.S. Physical Therapy's subsidiary, Metro Physical & Aquatic Therapy, has formed a 10-year alliance with NYU Langone Health, integrating Metro's 60 clinics into NYU Langone's network. This partnership has the potential to enhance referral flows, brand visibility, and care integration for U.S. Physical Therapy, which currently trades at a relatively high P/E. The financial impact of this alliance is yet to be quantified by management but could significantly influence the company's investment narrative and future profitability.
The Bull Case For U.S. Physical Therapy (USPH) Could Change Following NYU Langone Alliance - Learn Why
U.S. Physical Therapy's subsidiary, Metro Physical & Aquatic Therapy, has formed a 10-year alliance with NYU Langone Health, integrating its 60 clinics into NYU Langone’s network. This partnership could significantly impact U.S. Physical Therapy's investment outlook by potentially improving referrals and payer mix, though the financial specifics are yet to be disclosed. Investors are advised to await further details, especially concerning the economic impact, given the stock's current valuation.
Assessing U.S. Physical Therapy’s Valuation After Recent Share Price Momentum
U.S. Physical Therapy (USPH) has seen recent share price momentum, prompting an assessment of its valuation. Despite longer-term declines, the stock is showing near-term gains and is considered undervalued by some metrics, with a fair value estimated at $106.83 due to strategic cost efficiencies and growth drivers. However, its current P/E ratio of 34.9x is higher than the industry average, suggesting it might be overvalued when viewed through this lens.
Avoiding Lag: Real-Time Signals in (USPH) Movement
The article provides a real-time analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting a neutral sentiment in the near term with potential mid-term weakness. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis and specific entry, target, and stop-loss parameters. The analysis points to an exceptional 36.6:1 risk-reward setup for a potential 10.6% gain.
US Physical Therapy forms 10-year alliance with NYU Langone
US Physical Therapy has announced a 10-year strategic alliance with NYU Langone Health to manage its physical and occupational therapy centers. This partnership aims to enhance patient access and expand services through comprehensive rehabilitation care. Over 200 NYU Langone physical and occupational therapy clinic employees are expected to transition to US Physical Therapy, which will manage the operations of 34 clinics.
U S Physical Therapy Inc Announces Strategic Alliance and Acquisition
U.S. Physical Therapy, Inc. has announced a strategic alliance with NYU Langone Health and the acquisition of an industrial injury prevention business. The 10-year alliance with NYU Langone will significantly expand physical therapy services, incorporating Metro Physical Therapy's 60 clinics into NYU Langone's network. Additionally, the acquisition of a 70% stake in an industrial injury prevention business for $15.1 million is expected to add $7 million in annual revenue and diversify USPH's portfolio.
Workplace injury firm bought for $15.1M by U.S. Physical Therapy
U.S. Physical Therapy, Inc. (USPH) has acquired an industrial injury prevention business for approximately $15.1 million, gaining a 70% interest in the company which generates about $7.0 million in annual revenues. This acquisition expands USPH's service offerings in industrial injury prevention, including post-offer employment testing, functional capacity evaluations, and ergonomic assessments. The management team at USPH anticipates cross-selling opportunities with existing industrial injury prevention partners.
U.S. Physical Therapy acquires industrial injury prevention firm for $15.1m
U.S. Physical Therapy, Inc. (USPH) has acquired a 70% interest in an industrial injury prevention business for approximately $15.1 million, expanding its service offerings in this sector. The acquired company generates about $7.0 million in annual revenue. This move follows other recent strategic developments for USPH, including a strategic alliance with NYU Langone Health and a strong Market Outperform rating from Citizens.
US Physical Therapy Inc Acquisition Of Industrial Injury Prevention Business For About $15.1 Million
US Physical Therapy Inc. (USPH) has announced the acquisition of an industrial injury prevention business for approximately $15.1 million. This move is part of the company's strategy, as reported by Reuters. The financial details and other specifics of the acquisition were made public via a Refinitiv report.
U.S. Physical Therapy Announces the Acquisition of an Industrial Injury Prevention Business
U.S. Physical Therapy, Inc. (USPH) has acquired an industrial injury prevention business for approximately $15.1 million, which generates about $7.0 million in annual revenues. USPH obtained a 70% interest, with the remaining 30% retained by the previous owner. This acquisition expands USPH's offerings in industrial injury prevention services and is expected to create cross-selling opportunities.
3 Reasons to Avoid USPH and 1 Stock to Buy Instead
This article recommends avoiding U.S. Physical Therapy (USPH) despite its recent stock performance. The author highlights three main reasons: limited distribution channels due to its small size in a regulated industry, a declining free cash flow margin, and a decrease in Return on Invested Capital (ROIC). Instead, the article suggests exploring "high-quality stocks for all market conditions," particularly those showing strong momentum in digital advertising.
U.S. Physical Therapy Announces the Acquisition of an Industrial Injury Prevention Business
U.S. Physical Therapy, Inc. (USPH) has announced the acquisition of an industrial injury prevention business for approximately $15.1 million, which generates about $7.0 million in annual revenues. USPH acquired a 70% interest, with the remaining 30% retained by the previous owner. This acquisition expands USPH's offerings in industrial injury prevention services and is expected to create cross-selling opportunities.
U.S. Physical Therapy Announces Strategic Alliance with NYU Langone Health
U.S. Physical Therapy (USPH) has announced a 10-year strategic alliance between its subsidiary, Metro Physical & Aquatic Therapy, and NYU Langone Health. This collaboration will integrate Metro Physical Therapy's 60 outpatient clinics into NYU Langone's clinical services network to expand access to physical therapy in Long Island and the New York metropolitan area. USPH plans to disclose the financial details of this alliance during its year-end earnings release and conference call scheduled for February 25 and 26, 2026.
U.S. Physical Therapy Announces 10-Year Strategic Alliance With NYU Langone Health
U.S. Physical Therapy (USPH) has announced a 10-year strategic alliance with NYU Langone Health. This partnership was reported by Reuters and is categorized under strategy, business, and products.
Teacher Retirement System of Texas Has $1.39 Million Stock Position in U.S. Physical Therapy, Inc. $USPH
The Teacher Retirement System of Texas significantly reduced its stake in U.S. Physical Therapy (NYSE:USPH) by 71.8% in the third quarter, selling 41,784 shares and retaining a position valued at approximately $1.39 million. Despite this reduction by one institutional investor, other firms like Cullen Frost Bankers Inc. and Assetmark Inc. increased their holdings. U.S. Physical Therapy reported mixed quarterly results, with EPS missing estimates but revenue beating expectations and increasing 17.3% year-over-year.
U.S. Physical Therapy Announces the Acquisition of an Industrial Injury Prevention Business
U.S. Physical Therapy, Inc. (USPH) acquired an industrial injury prevention business for approximately $15.1 million, which generates about $7.0 million in annual revenues. USPH obtained a 70% interest, with the previous owner retaining 30%. This acquisition expands USPH's industrial injury prevention services and is expected to offer cross-selling opportunities with existing partners.
U.S. Physical Therapy (NYSE:USPH) Stock Price Crosses Above 200-Day Moving Average - What's Next?
U.S. Physical Therapy (NYSE:USPH) stock has crossed above its 200-day moving average, signaling a potential bullish trend, trading at $82.30 on Thursday. Analysts maintain a "Moderate Buy" rating with an average target price of $105.33, despite a recent target trim by JPMorgan. The company reported a $1.25 billion market cap, a PE ratio of 34.58, 17.3% year-over-year revenue growth, and pays a quarterly dividend of $0.45.
We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt
U.S. Physical Therapy (NYSE:USPH) has a manageable debt load, with net debt at 1.3 times EBITDA and strong interest coverage. The company's ability to convert EBIT to free cash flow is robust, reaching 91% over the last three years. This financial health suggests that despite having debt, USPH is in a strong position to manage its obligations and pursue growth.
Discipline and Rules-Based Execution in USPH Response
This article from Stock Traders Daily discusses U.S. Physical Therapy Inc. (USPH) with a focus on rules-based execution. It highlights neutral near-term readings, strong mid-term sentiment that may be stalling, and a mid-channel oscillation pattern. The analysis includes a favorable risk-reward setup, AI-generated trading strategies for different risk profiles, and multi-timeframe signal analysis.
U S Physical Therapy Faces Rising Competition And Capital Strain
U.S. Physical Therapy (NYSE:USPH) is experiencing increased competition, leading to shrinking returns on capital and higher capital intensity. This trend indicates that the company needs to invest more capital to maintain its market position, raising concerns about its business model's efficiency and future scaling. Despite recent earnings growth, investors need to monitor whether capital returns stabilize and if earnings growth can justify the increased capital burden in a competitive outpatient market.
U S Physical Therapy Faces Rising Competition And Capital Strain
U.S. Physical Therapy (NYSE:USPH) is facing increased competition, leading to shrinking returns on capital and higher capital intensity in its clinic network. This trend suggests the company needs to invest more to maintain its market position, impacting profitability and efficiency. While recent earnings show significant growth, the long-term performance has been mixed, and the company's ability to maintain clinic productivity against higher investment will be key for future profitability.
U.S. Physical Therapy, Inc. (NYSE:USPH) Given Average Rating of "Moderate Buy" by Analysts
U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus "Moderate Buy" rating from seven analysts, with an average 12-month price target of $105.33. The company recently reported quarterly earnings of $0.66 EPS, missing estimates by $0.01, but saw revenue increase by 17.3% year-over-year to $197.13 million. USPH also declared a quarterly dividend of $0.45, contributing to an annualized yield of 2.1%.
U.S. Physical Therapy (USPH) Is Up 8.1% After 17.3% Revenue Gain And Upbeat Analyst Sentiment
U.S. Physical Therapy, Inc. (USPH) has seen an 8.1% increase in its stock price, driven by a 17.3% rise in revenue and positive analyst sentiment. The company’s clinic-based model continues to convert patient demand into revenue, supported by a recent US$25 million share repurchase authorization. Analysts project significant revenue and earnings growth for USPH by 2028, with a fair value estimate suggesting a 24% upside from its current price.
U.S. Physical Therapy Presented at the J.P. Morgan 2026 Healthcare Conference
U.S. Physical Therapy, Inc. (USPH) announced that its CEO, Chris Reading, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company is a national operator of outpatient physical therapy clinics and a provider of industrial injury prevention services, managing 780 clinics across 44 states. USPH also shared recent financial results and acquisition news.
How a 780-clinic therapy network landed on J.P. Morgan's 2026 stage
U.S. Physical Therapy, Inc. (USPH) announced that its CEO, Chris Reading, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company, founded in 1990, owns and/or manages 780 outpatient physical therapy clinics across 44 states and also provides industrial injury prevention services. This presentation highlights the company's significant presence and services within the healthcare industry.
U.S. Physical Therapy (USPH) Is Up 8.1% After 17.3% Revenue Gain And Upbeat Analyst Sentiment
U.S. Physical Therapy (USPH) has seen an 8.1% increase in its stock price following a 17.3% revenue gain and positive analyst sentiment. The company's clinic-based model continues to convert patient demand into revenue, and a new US$25,000,000 share repurchase authorization further supports management's confidence. Despite these positive indicators, potential reimbursement pressure remains a long-term risk.
U.S. Physical Therapy Presented at the J.P. Morgan 2026 Healthcare Conference
U.S. Physical Therapy, Inc. (USPH) announced that its CEO, Chris Reading, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company, founded in 1990, operates and/or manages 780 outpatient physical therapy clinics across 44 states and also provides industrial injury prevention services. USPH focuses on preventative and post-operative care for orthopedic and sports-related injuries, neurological rehabilitation, and services for injured workers.
U.S. Physical Therapy Presented at the J.P. Morgan 2026 Healthcare Conference
U.S. Physical Therapy, Inc. (USPH) announced that its Chief Executive Officer, Chris Reading, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company, founded in 1990, operates 780 outpatient physical therapy clinics across 44 states and also provides industrial injury prevention services. USPH offers various services including preventative care, post-operative care, treatment for neurological injuries, and rehabilitation for injured workers.
Behavioral Patterns of USPH and Institutional Flows
This article analyzes U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting a strong near-to mid-term sentiment and a mid-channel oscillation pattern. It presents three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The analysis also includes multi-timeframe signal insights and offers access to real-time signals and personalized alerts.
Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock?
The options market is showing high implied volatility for U.S. Physical Therapy (USPH), particularly with the Mar 20, 2026 $80 Put, suggesting investors anticipate a significant price movement. Despite this, the company currently holds a Zacks Rank #4 (Sell), with analysts revising earnings estimates downwards. This situation may appeal to options traders looking to sell premium.
Is U.S. Physical Therapy, Inc.'s (NYSE:USPH) Stock On A Downtrend As A Result Of Its Poor Financials?
U.S. Physical Therapy's stock is down 7.1% over the past three months, prompting an examination of its financials. Despite a 7.8% Return on Equity (ROE), which is below the industry average of 15%, the company has seen a significant 4.9% decline in net income over the last five years. This downturn is attributed to the company spending most of its profits on dividends, with an 87% payout ratio, leaving little for reinvestment and hindering earnings growth.
U S Physical Therapy Inc Acquires 50% Interest in Management Services Company
U.S. Physical Therapy, Inc. (USPH) announced on January 5, 2026, the acquisition of a 50% interest in a physical therapy management services company. This new acquisition manages eight clinics, generates around $8 million in annual revenues, and handles approximately 66,000 annual visits. The current owners will retain the other 50% ownership, expanding USPH's service offerings and partnerships.
The Bull Case For U.S. Physical Therapy (USPH) Could Change Following 50% Stake In Eight-Clinic Platform
U.S. Physical Therapy (USPH) recently acquired a 50% stake in a physical therapy management services company overseeing eight outpatient clinics, generating about US$8 million in annual revenue. This partnership model is consistent with USPH's strategy of disciplined expansion to offset industry pressures, though the acquisition alone doesn't significantly alter short-term growth catalysts or reimbursement risks. Analysts project USPH's revenue to reach $918.4 million and earnings $52.5 million by 2028, suggesting a potential 35% upside to its current price.
U.S. Physical Therapy acquires 50% stake in therapy management firm
U.S. Physical Therapy (NYSE:USPH) announced it acquired a 50% interest in a physical therapy management services company overseeing eight clinics, aligning with its growth strategy. This acquisition adds approximately $8.0 million in annual revenue and 66,000 patient visits, representing less than 1% of USPH's total revenue. The company also recently reported mixed Q3 2025 earnings and received a "Market Outperform" rating from Citizens.
Eight physical therapy clinics gain a new national partner
U.S. Physical Therapy, Inc. (USPH) has acquired a 50% interest in a physical therapy management services company that manages eight clinics, generating approximately $8.0 million in annual revenues. This acquisition expands USPH's service offerings and its presence in the physical therapy market. The company aims to support its newest partners in continuing to build their foundation and provide outstanding clinical care.
U.S. Physical Therapy Announces the Acquisition of an Eight-Clinic Physical Therapy Management Services Company
U.S. Physical Therapy, Inc. (USPH) announced the acquisition of a physical therapy management services company that manages eight clinics, generating approximately $8.0 million in annual revenues and 66,000 annual visits. USPH acquired a 50% interest, with the remaining 50% retained by the current owners. This acquisition expands USPH's service offerings and partner network.
The Bull Case For U.S. Physical Therapy (USPH) Could Change Following 50% Stake In Eight-Clinic Platform
U.S. Physical Therapy (USPH) recently acquired a 50% stake in a physical therapy management services company that operates eight outpatient clinics, generating about $8 million in annual revenue. This partnership is consistent with USPH's strategy of expanding its clinic footprint and supporting revenue growth, though it doesn't significantly alter the immediate challenges of reimbursement and labor pressures. Analysts project USPH's revenue to reach $918.4 million and earnings to hit $52.5 million by 2028, with a fair value estimate of $106.83, suggesting a 35% upside.
U.S. Physical Therapy (NYSE:USPH) Sees Large Volume Increase - Should You Buy?
U.S. Physical Therapy (NYSE:USPH) saw an 88% surge in trading volume on Monday, with shares jumping approximately 7% to $83.995. Analysts currently have a consensus "Moderate Buy" rating for the stock, with a target price of $105.33, despite recent adjustments from firms like JPMorgan. The company reported strong Q3 earnings of $0.90 EPS on $140.66M revenue and pays a quarterly dividend of $0.45.
The Bull Case For U.S. Physical Therapy (USPH) Could Change Following 50% Stake In Eight-Clinic Platform
U.S. Physical Therapy (USPH) recently acquired a 50% interest in a physical therapy management services company overseeing eight outpatient clinics, generating US$8 million in annual revenue. This partnership expands USPH's footprint while sharing risk, aligning with its strategy of clinic expansion to offset reimbursement and labor pressures. However, the acquisition's scale does not materially alter the main short-term challenge of sustained visit growth or the ongoing risk of payer pressure.
U.S. Physical Therapy Acquires Eight-Clinic Physical Therapy Management Services Company
U.S. Physical Therapy, Inc. has announced the acquisition of a physical therapy management services company that exclusively manages an eight-clinic physical therapy practice. This acquisition is expected to generate approximately $8.0 million in annual revenues and 66,000 annual visits. USPH acquired a 50% interest, with the remaining 50% retained by the current owners, expanding their service offerings and strengthening their presence in the physical therapy market.
New Analyst Forecast: $USPH Given $103 Price Target
Barrington Research analyst Michael Petusky has set a new price target of $103.0 for USPH. This new target contributes to a median analyst target of $101.5 from two analysts in the last six months. The article also details recent insider trading activity, with more sales than purchases, and significant institutional investor activity in Q3 2025.
U.S. Physical Therapy's (USPH) Outperform Rating Reaffirmed at Barrington Research
Barrington Research reaffirmed an "Outperform" rating on U.S. Physical Therapy (NYSE:USPH) with a $103.00 price target, suggesting a potential upside of 25.9% from its previous close. The stock currently holds a "Moderate Buy" consensus rating with an average analyst target of $105.33, and its shares recently rose 3.7% to $81.80 on above-average volume. Several other firms have also commented on USPH, with some downgrades to "hold" and others reiterating "overweight" or "market outperform" ratings.
USPH: Barrington Research Maintains 'Outperform' Rating with $103 PT | USPH Stock News
Barrington Research has reaffirmed its 'Outperform' rating for US Physical Therapy (USPH) with a consistent price target of $103. This indicates a stable outlook from Barrington Research, with no change in the target percentage. The average target price from 5 analysts is $103.60, suggesting a 25.55% upside from the current price.
Why Are U.S. Physical Therapy (USPH) Shares Soaring Today
U.S. Physical Therapy (USPH) shares jumped 6.5% after the company announced the acquisition of a 50% interest in a physical therapy management services company that generates $8.0 million in annual revenues. This acquisition aligns with the company's growth strategy and was further supported by Barrington Research setting a new price target of $103 for the stock. This news, coupled with a recent RBC Capital upgrade for the healthcare sector, suggests positive market sentiment for USPH.
(USPH) Movement Within Algorithmic Entry Frameworks
This article details algorithmic entry frameworks for U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting weak near-term sentiment but strong risk-reward short setups. It presents three distinct trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, alongside multi-timeframe signal analysis. The piece also emphasizes real-time AI-generated signals and institutional-grade analysis for subscribers.
Copeland Capital Management LLC Sells 44,754 Shares of U.S. Physical Therapy, Inc. $USPH
Copeland Capital Management LLC reduced its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.0% in the third quarter, selling 44,754 shares but still holding 843,981 shares valued at $71.7 million, representing 5.55% of the company. The stock currently has a "Moderate Buy" consensus rating and a target price of $105.33, with a recent quarterly dividend of $0.45 per share.
